Efficacy of ZenthOnc-Alpha in Advanced NSCLC
Non-Small Cell Lung Cancer / Oncology
Transparent, rigorous, and patient-centered clinical research advancing next-generation therapeutics, gene therapies, and precision medicine worldwide.
Non-Small Cell Lung Cancer / Oncology
Neurodegenerative Disorders / Neurological
Hyperlipidemia / Cardiovascular
Rare Genetic Disorders / Metabolic
Pancreatic Cancer / Oncology
Cardiac Arrhythmia / Cardiovascular
All Aevum Zenth clinical trials are conducted in strict adherence to international regulatory frameworks, prioritizing patient safety, data integrity, and transparent reporting.
Every protocol undergoes rigorous independent ethical review before initiation, ensuring informed consent and patient rights.
Trials follow 21 CFR Part 11, ICH-GCP guidelines, and EU Clinical Trials Regulation No 536/2014 standards.
Participant data is encrypted, anonymized, and stored in certified secure infrastructure with zero third-party leakage.
Positive and negative results are published transparently. Datasets are shared with qualified researchers upon request.
Explore eligible studies, understand enrollment criteria, or speak with our patient advocacy team for confidential guidance.
Find a Trial Near YouJoin our global network of academic medical centers, contract research organizations, and clinical sites.
Partner With Zenth Health